E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/18/2016 in the Prospect News Investment Grade Daily.

Light volume forecast for holiday week; Abbott, Pfizer mixed; Chevron Phillips Chemical firms

By Cristal Cody

Eureka Springs, Ark., Nov. 18 – High-grade primary action stayed quiet on Friday, and light volume is expected over the Thanksgiving Day holiday week, according to sources on Friday.

About $5 billion to as much as $10 billion of issuance is forecast with most of the action front-loaded in the week ahead, a source said.

The Markit CDX North American Investment Grade index softened 2 basis points over the day to close at a spread of 77 bps.

In the secondary market, Abbott Laboratories’ $15.1 billion of senior notes (Baa3/A+) priced in six tranches on Thursday were mixed Friday.

Pfizer Inc.’s $6 billion of notes (A1/AA/A+) sold in five tranches on Monday traded flat to about 3 bps better than issuance on Friday.

Chevron Phillips Chemical Co. LLC’s 3.4% senior notes due 2026 brought to market on Thursday firmed 6 bps on the bid side.

Abbot mixed

Abbott Laboratories’ 2.35% notes due 2019 improved to 103 bps bid, 101 bps offered in secondary trading, a source said. The company sold $2.85 billion of the notes on Thursday at 105 bps over Treasuries.

Abbott’s 3.75% notes due 2026 softened to 156 bps bid, 153 bps offered on Friday. The $3 billion tranche priced on Thursday at a spread of 155 bps over Treasuries.

The pharmaceutical health-care products company is based in Abbott Park, Ill.

Pfizer flat to better

Pfizer’s 3% notes due 2026 traded at 82 bps bid, 81 bps offered on Friday, according to a market source.

The company sold $1.75 billion of the 10-year notes on Monday at a spread of 85 bps over Treasuries.

Pfizer’s 4.125% notes due 2046 were quoted at 110 bps bid, 108 bps offered in the secondary market.

The long bonds priced in a $1.25 billion tranche on Monday at a spread of 110 bps over Treasuries.

The biopharmaceutical company is based in Foster City, Calif.

Chevron Phillips improves

Chevron Phillips Chemical’s 3.4% senior notes due 2026 tightened to 109 bps bid, 107 bps offered in secondary trading, a market source said on Friday.

The company sold $700 million of the 10-year notes (A2/A-/) on Thursday at a spread of 115 bps plus Treasuries.

Chevron Phillips Chemical is a Woodlands, Texas-based petrochemical company owned by Chevron Corp. and Phillips 66.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.